MARKET

MGTX

MGTX

Meiragtx Holdings Plc
NASDAQ
8.65
+0.05
+0.58%
After Hours: 8.65 0 0.00% 17:01 12/05 EST
OPEN
8.59
PREV CLOSE
8.60
HIGH
8.72
LOW
8.45
VOLUME
510.75K
TURNOVER
--
52 WEEK HIGH
9.73
52 WEEK LOW
4.550
MARKET CAP
696.25M
P/E (TTM)
-4.1015
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MGTX last week (1124-1128)?
Weekly Report · 6d ago
MeiraGTx Holdings Initiated at Buy by HC Wainwright & Co.
Dow Jones · 11/24 15:24
MeiraGTx Holdings Price Target Announced at $20.00/Share by HC Wainwright & Co.
Dow Jones · 11/24 15:24
HC Wainwright & Co. Initiates Coverage On MeiraGTx Hldgs with Buy Rating, Announces Price Target of $20
Benzinga · 11/24 15:14
MeiraGTx initiated with a Buy at H.C. Wainwright
TipRanks · 11/24 11:15
MEIRAGTX HOLDINGS PLC <MGTX.O>: H.C. WAINWRIGHT INITIATES COVERAGE WITH BUY RATING AND TARGET PRICE $20
Reuters · 11/24 11:11
Weekly Report: what happened at MGTX last week (1117-1121)?
Weekly Report · 11/24 09:15
U.S. RESEARCH ROUNDUP-Alignment Healthcare, BJ's Wholesale Club Holdings, Hyatt Hotels
Reuters · 11/24 08:05
More
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.

Webull offers MeiraGTx Holdings PLC stock information, including NASDAQ: MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.